AHSZX : Alger Health Sciences Fund Class Z

AHSZX is a Sector Equity Market Healthcare with MODERATE fees.

AHSZX

Alger Health Sciences Fund Class Z

FI Score

33 /100

Expense Ratio Rating

6 /10

Expense Rating

3 /10

Market Score

3 /10

Category Score

0 /10

Market Size

3 /10

33% FI Score
  • ahszx
  • Mutual Fund
  • Sector Equity
  • Healthcare

Alger Health Sciences Fund Class Z

Expenses: 0.75% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why ยป

Fund Summary

The investment seeks long-term capital appreciation. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies of any market capitalization that are engaged in the health sciences sector. It can invest in foreign securities.

Largest Holdings

Amount Holding
4.94% Vertex Pharmaceuticals Inc
4.81% UnitedHealth Group Inc
4.03% DexCom Inc
3.62% Eli Lilly and Co
3.07% Bristol-Myers Squibb Company
2.96% Gilead Sciences Inc
2.93% Tolero Cdr/Rec
2.87% AbbVie Inc
2.79% Sarepta Therapeutics Inc
2.74% Danaher Corp
2.60% Thermo Fisher Scientific Inc
2.60% Merck & Co Inc
2.52% Abbott Laboratories
2.48% AstraZeneca PLC ADR
2.44% Biogen Inc
2.24% Regeneron Pharmaceuticals Inc
2.23% Novartis AG ADR
1.92% Insulet Corp
1.90% Teladoc Health Inc
1.88% Cigna Corp
1.87% eHealth Inc
1.71% Allergan PLC
1.59% Humana Inc
1.59% Zoetis Inc Class A
1.44% GW Pharmaceuticals PLC ADR

Minafi - The intersection of FI, minimalism & mindfulness.

Don't miss out on new posts, courses, interactive articles and more!

Join & Get Your First Course Free

© 2024   Adam Fortuna

Site Map
Triangle Graduation Cap Angle Down Book regular Phone laptop regular fire regular fire regular search regular Acorn duotone Seedling duotone thumbs down duo thumbs up duo